How will Medical Devices be regulated following the end of the Brexit Transition Period?
From 1 January 2021, the transition period after Brexit ended, and the Medicines and Healthcare products Regulatory Agency (MHRA) took on the role as the UK’s standalone medicines and medical devices regulator. On 1 September 2020, the MHRA published a set of guidance on what the rules will be from 1 January 2021. The guidance on medical devices have been subsequently updated on 21st October, 4th November and 31st December.
Our PharmaLex.perts have created an interesting Whitepaper, which introduces you to important current considerations about the new MDR following the end of the Brexit Transition Period.